molecular function |
| GO:0005524 | | ATP binding | | Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
| GO:0051059 | | NF-kappaB binding | | Interacting selectively and non-covalently with NF-kappaB, a transcription factor for eukaryotic RNA polymerase II promoters. |
| GO:0001085 | | RNA polymerase II transcription factor binding | | Interacting selectively and non-covalently with an RNA polymerase II transcription factor, any protein required to initiate or regulate transcription by RNA polymerase II. |
| GO:0008013 | | beta-catenin binding | | Interacting selectively and non-covalently with the beta subunit of the catenin complex. |
| GO:0005178 | | integrin binding | | Interacting selectively and non-covalently with an integrin. |
| GO:0035255 | | ionotropic glutamate receptor binding | | Interacting selectively and non-covalently with an ionotropic glutamate receptor. Ionotropic glutamate receptors bind glutamate and exert an effect through the regulation of ion channels. |
| GO:0016301 | | kinase activity | | Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule. |
| GO:0000166 | | nucleotide binding | | Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose. |
| GO:0002039 | | p53 binding | | Interacting selectively and non-covalently with one of the p53 family of proteins. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| GO:0034236 | | protein kinase A catalytic subunit binding | | Interacting selectively and non-covalently with one or both of the catalytic subunits of protein kinase A. |
| GO:0004672 | | protein kinase activity | | Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP. |
| GO:0019901 | | protein kinase binding | | Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. |
| GO:0004674 | | protein serine/threonine kinase activity | | Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate. |
| GO:0048156 | | tau protein binding | | Interacting selectively and non-covalently with tau protein. tau is a microtubule-associated protein, implicated in Alzheimer's disease, Down Syndrome and ALS. |
| GO:0050321 | | tau-protein kinase activity | | Catalysis of the reaction: ATP + tau-protein = ADP + O-phospho-tau-protein. |
| GO:0008134 | | transcription factor binding | | Interacting selectively and non-covalently with a transcription factor, any protein required to initiate or regulate transcription. |
| GO:0016740 | | transferase activity | | Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2. |
| GO:0031625 | | ubiquitin protein ligase binding | | Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins. |
biological process |
| GO:0006983 | | ER overload response | | The series of molecular signals generated by the accumulation of normal or misfolded proteins in the endoplasmic reticulum and leading to activation of transcription by NF-kappaB. |
| GO:0016055 | | Wnt signaling pathway | | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell and ending with a change in cell state. |
| GO:0007568 | | aging | | A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700). |
| GO:0009887 | | animal organ morphogenesis | | Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions. |
| GO:0007409 | | axonogenesis | | De novo generation of a long process of a neuron, that carries efferent (outgoing) action potentials from the cell body towards target cells. Refers to the morphogenesis or creation of shape or form of the developing axon. |
| GO:1904885 | | beta-catenin destruction complex assembly | | The aggregation, arrangement and bonding together of a set of components to form a beta-catenin destruction complex. |
| GO:1904886 | | beta-catenin destruction complex disassembly | | The disaggregation of a beta-catenin destruction complex into its constituent components. |
| GO:0060070 | | canonical Wnt signaling pathway | | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes. |
| GO:0044337 | | canonical Wnt signaling pathway involved in positive regulation of apoptotic process | | The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes involved in the positive regulation of apoptotic process. |
| GO:0005975 | | carbohydrate metabolic process | | The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y. Includes the formation of carbohydrate derivatives by the addition of a carbohydrate residue to another molecule. |
| GO:0030154 | | cell differentiation | | The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state. |
| GO:0016477 | | cell migration | | The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms. |
| GO:1903351 | | cellular response to dopamine | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dopamine stimulus. |
| GO:0036018 | | cellular response to erythropoietin | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an erythropoietin stimulus. |
| GO:0035729 | | cellular response to hepatocyte growth factor stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hepatocyte growth factor stimulus. |
| GO:0070301 | | cellular response to hydrogen peroxide | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus. |
| GO:0036016 | | cellular response to interleukin-3 | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-3 stimulus. |
| GO:0071282 | | cellular response to iron(II) ion | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron(II) ion stimulus. |
| GO:0071285 | | cellular response to lithium ion | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lithium (Li+) ion stimulus. |
| GO:0071260 | | cellular response to mechanical stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus. |
| GO:0099565 | | chemical synaptic transmission, postsynaptic | | The part of synaptic transmission occurring in the post-synapse: a signal transduction pathway consisting of neurotransmitter receptor activation and its effects on postsynaptic membrane potential and the ionic composition of the postsynaptic cytosol. |
| GO:0007623 | | circadian rhythm | | Any biological process in an organism that recurs with a regularity of approximately 24 hours. |
| GO:0007212 | | dopamine receptor signaling pathway | | The series of molecular signals generated as a consequence of a dopamine receptor binding to one of its physiological ligands. |
| GO:0001837 | | epithelial to mesenchymal transition | | A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell. |
| GO:0030010 | | establishment of cell polarity | | The specification and formation of anisotropic intracellular organization or cell growth patterns. |
| GO:0007163 | | establishment or maintenance of cell polarity | | Any cellular process that results in the specification, formation or maintenance of anisotropic intracellular organization or cell growth patterns. |
| GO:0097192 | | extrinsic apoptotic signaling pathway in absence of ligand | | A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with withdrawal of a ligand from a cell surface receptor, and ends when the execution phase of apoptosis is triggered. |
| GO:0045444 | | fat cell differentiation | | The process in which a relatively unspecialized cell acquires specialized features of an adipocyte, an animal connective tissue cell specialized for the synthesis and storage of fat. |
| GO:0005977 | | glycogen metabolic process | | The chemical reactions and pathways involving glycogen, a polydisperse, highly branched glucan composed of chains of D-glucose residues in alpha-(1->4) glycosidic linkage, joined together by alpha-(1->6) glycosidic linkages. |
| GO:0021766 | | hippocampus development | | The progression of the hippocampus over time from its initial formation until its mature state. |
| GO:0044027 | | hypermethylation of CpG island | | An increase in the epigenetic methylation of cytosine and adenosine residues in a CpG island in DNA. CpG islands are genomic regions that contain a high frequency of the CG dinucleotide and are often associated with the transcription start site of genes. |
| GO:0035556 | | intracellular signal transduction | | The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. |
| GO:0070059 | | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | | A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced in response to a stimulus indicating endoplasmic reticulum (ER) stress, and ends when the execution phase of apoptosis is triggered. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen. |
| GO:0007275 | | multicellular organism development | | The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult). |
| GO:0007520 | | myoblast fusion | | A process in which non-proliferating myoblasts fuse to existing fibers or to myotubes to form new fibers. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers. |
| GO:0014902 | | myotube differentiation | | The process in which a relatively unspecialized cell acquires specialized features of a myotube cell. Myotube differentiation starts with myoblast fusion and the appearance of specific cell markers (this is the cell development step). Then individual myotubes can fuse to form bigger myotubes and start to contract. Myotubes are multinucleated cells that are formed when proliferating myoblasts exit the cell cycle, differentiate and fuse. |
| GO:0043407 | | negative regulation of MAP kinase activity | | Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity. |
| GO:0051534 | | negative regulation of NFAT protein import into nucleus | | Any process that stops, prevents, or reduces the frequency, rate or extent of the movement of an NFAT protein from the cytoplasm to the nucleus. |
| GO:0043066 | | negative regulation of apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
| GO:0090090 | | negative regulation of canonical Wnt signaling pathway | | Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. |
| GO:0010614 | | negative regulation of cardiac muscle hypertrophy | | Any process that decreases the rate, frequency or extent of the enlargement or overgrowth of all or part of the heart due to an increase in size (not length) of individual cardiac muscle fibers, without cell division. |
| GO:2000171 | | negative regulation of dendrite development | | Any process that stops, prevents, or reduces the frequency, rate or extent of dendrite development. |
| GO:0050774 | | negative regulation of dendrite morphogenesis | | Any process that stops, prevents, or reduces the frequency, rate or extent of dendrite morphogenesis. |
| GO:1904339 | | negative regulation of dopaminergic neuron differentiation | | Any process that stops, prevents or reduces the frequency, rate or extent of dopaminergic neuron differentiation. |
| GO:2000466 | | negative regulation of glycogen (starch) synthase activity | | Any process that stops, prevents or reduces the frequency, rate or extent of glycogen (starch) synthase activity. |
| GO:0045719 | | negative regulation of glycogen biosynthetic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glycogen. |
| GO:0014043 | | negative regulation of neuron maturation | | Any process that stops, prevents, or reduces the frequency, rate or extent of neuron maturation. |
| GO:2001223 | | negative regulation of neuron migration | | Any process that stops, prevents or reduces the frequency, rate or extent of neuron migration. |
| GO:0010977 | | negative regulation of neuron projection development | | Any process that decreases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites). |
| GO:0051001 | | negative regulation of nitric-oxide synthase activity | | Any process that stops or reduces the activity of the enzyme nitric-oxide synthase. |
| GO:0032091 | | negative regulation of protein binding | | Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding. |
| GO:0031333 | | negative regulation of protein complex assembly | | Any process that stops, prevents, or reduces the frequency, rate or extent of protein complex assembly. |
| GO:1900181 | | negative regulation of protein localization to nucleus | | Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to nucleus. |
| GO:0009968 | | negative regulation of signal transduction | | Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction. |
| GO:0034392 | | negative regulation of smooth muscle cell apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate, or extent of smooth muscle cell apoptotic process. |
| GO:2000077 | | negative regulation of type B pancreatic cell development | | Any process that stops, prevents, or reduces the frequency, rate or extent of pancreatic B cell development. |
| GO:0007399 | | nervous system development | | The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state. |
| GO:0018105 | | peptidyl-serine phosphorylation | | The phosphorylation of peptidyl-serine to form peptidyl-O-phospho-L-serine. |
| GO:0018107 | | peptidyl-threonine phosphorylation | | The phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine. |
| GO:0016310 | | phosphorylation | | The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide. |
| GO:2000573 | | positive regulation of DNA biosynthetic process | | Any process that activates or increases the frequency, rate or extent of DNA biosynthetic process. |
| GO:0043547 | | positive regulation of GTPase activity | | Any process that activates or increases the activity of a GTPase. |
| GO:0043065 | | positive regulation of apoptotic process | | Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. |
| GO:0045773 | | positive regulation of axon extension | | Any process that activates or increases the frequency, rate or extent of axon extension. |
| GO:0001954 | | positive regulation of cell-matrix adhesion | | Any process that activates or increases the rate or extent of cell adhesion to an extracellular matrix. |
| GO:2000463 | | positive regulation of excitatory postsynaptic potential | | Any process that enhances the establishment or increases the extent of the excitatory postsynaptic potential (EPSP) which is a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential. |
| GO:0010918 | | positive regulation of mitochondrial membrane potential | | Any process that activates or increases the frequency, rate or extent of establishment or extent of a mitochondrial membrane potential, the electric potential existing across any mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane. |
| GO:1901030 | | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | | Any process that activates or increases the frequency, rate or extent of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway. |
| GO:0043525 | | positive regulation of neuron apoptotic process | | Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process. |
| GO:1901216 | | positive regulation of neuron death | | Any process that activates or increases the frequency, rate or extent of neuron death. |
| GO:0033138 | | positive regulation of peptidyl-serine phosphorylation | | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine. |
| GO:0010800 | | positive regulation of peptidyl-threonine phosphorylation | | Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine. |
| GO:0032436 | | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | | Any process that activates or increases the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome. |
| GO:0032092 | | positive regulation of protein binding | | Any process that activates or increases the frequency, rate or extent of protein binding. |
| GO:0045732 | | positive regulation of protein catabolic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds. |
| GO:0031334 | | positive regulation of protein complex assembly | | Any process that activates or increases the frequency, rate or extent of protein complex assembly. |
| GO:0046827 | | positive regulation of protein export from nucleus | | Any process that activates or increases the frequency, rate or extent of directed movement of proteins from the nucleus into the cytoplasm. |
| GO:0048661 | | positive regulation of smooth muscle cell proliferation | | Any process that activates or increases the rate or extent of smooth muscle cell proliferation. |
| GO:2000738 | | positive regulation of stem cell differentiation | | Any process that activates or increases the frequency, rate or extent of stem cell differentiation. |
| GO:0045944 | | positive regulation of transcription from RNA polymerase II promoter | | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| GO:0043161 | | proteasome-mediated ubiquitin-dependent protein catabolic process | | The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome. |
| GO:0046777 | | protein autophosphorylation | | The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation). |
| GO:0006611 | | protein export from nucleus | | The directed movement of a protein from the nucleus into the cytoplasm. |
| GO:0035372 | | protein localization to microtubule | | A process in which a protein is transported to, or maintained at, a microtubule. |
| GO:0006468 | | protein phosphorylation | | The process of introducing a phosphate group on to a protein. |
| GO:0000320 | | re-entry into mitotic cell cycle | | The resumption of the mitotic cell division cycle by cells that were in a quiescent or other non-dividing state. |
| GO:0030516 | | regulation of axon extension | | Any process that modulates the rate, direction or extent of axon extension. |
| GO:0050770 | | regulation of axonogenesis | | Any process that modulates the frequency, rate or extent of axonogenesis, the generation of an axon, the long process of a neuron. |
| GO:1900034 | | regulation of cellular response to heat | | Any process that modulates the frequency, rate or extent of cellular response to heat. |
| GO:0048814 | | regulation of dendrite morphogenesis | | Any process that modulates the frequency, rate or extent of dendrite morphogenesis. |
| GO:0006349 | | regulation of gene expression by genetic imprinting | | Heritable alterations in the activity of a gene that depend on whether it passed through the paternal or the maternal germline, but that are not encoded by DNA itself. |
| GO:0032886 | | regulation of microtubule-based process | | Any process that modulates the frequency, rate or extent of any cellular process that depends upon or alters the microtubule cytoskeleton. |
| GO:0010975 | | regulation of neuron projection development | | Any process that modulates the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites). |
| GO:0048168 | | regulation of neuronal synaptic plasticity | | A process that modulates neuronal synaptic plasticity, the ability of neuronal synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers. |
| GO:1902065 | | response to L-glutamate | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an L-glutamate stimulus. |
| GO:0014823 | | response to activity | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an activity stimulus. |
| GO:1990776 | | response to angiotensin | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an angiotensin stimulus. Angiotensin is any of three physiologically active peptides (angiotensin II, III, or IV) processed from angiotensinogen. |
| GO:0042493 | | response to drug | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease. |
| GO:0071871 | | response to epinephrine | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epinephrine stimulus. Epinephrine is a catecholamine that has the formula C9H13NO3; it is secreted by the adrenal medulla to act as a hormone, and released by certain neurons to act as a neurotransmitter active in the central nervous system. |
| GO:0032355 | | response to estradiol | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen. |
| GO:0032868 | | response to insulin | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms. |
| GO:1990418 | | response to insulin-like growth factor stimulus | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin-like growth factor stimulus. |
| GO:0010226 | | response to lithium ion | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lithium (Li+) ion stimulus. |
| GO:1990478 | | response to ultrasound | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultrasonic stimulus. |
| GO:0048511 | | rhythmic process | | Any process pertinent to the generation and maintenance of rhythms in the physiology of an organism. |
| GO:0071109 | | superior temporal gyrus development | | The process whose specific outcome is the progression of the superior temporal gyrus over time, from its formation to the mature structure. The superior temporal gyrus is a portion of the cerebral cortex that extends from the lateral sulcus to the superior temporal sulcus. |
cellular component |
| GO:1990909 | | Wnt signalosome | | A multiprotein protein complex containing membrane-localized Wnt receptors and cytosolic protein complexes, which is capable of transmitting the Wnt signal. Contains at least a Wnt protein, LRP5 or LRP6, a member of the Frizzled (Fz) family, Axin and and a Dishevelled (DVL) protein. |
| GO:0030424 | | axon | | The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter. |
| GO:0030877 | | beta-catenin destruction complex | | A cytoplasmic protein complex containing glycogen synthase kinase-3-beta (GSK-3-beta), the adenomatous polyposis coli protein (APC), and the scaffolding protein axin, among others; phosphorylates beta-catenin, targets it for degradation by the proteasome. |
| GO:0044297 | | cell body | | The portion of a cell bearing surface projections such as axons, dendrites, cilia, or flagella that includes the nucleus, but excludes all cell projections. |
| GO:0005813 | | centrosome | | A structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle. |
| GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| GO:0030425 | | dendrite | | A neuron projection that has a short, tapering, often branched, morphology, receives and integrates signals from other neurons or from sensory stimuli, and conducts a nerve impulse towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body. |
| GO:0043198 | | dendritic shaft | | Cylindric portion of the dendrite, directly stemming from the perikaryon, and carrying the dendritic spines. |
| GO:0043197 | | dendritic spine | | A small, membranous protrusion from a dendrite that forms a postsynaptic compartment - typically receiving input from a single presynapse. They function as partially isolated biochemical and an electrical compartments. Spine morphology is variable including "thin", "stubby", "mushroom", and "branched", with a continuum of intermediate morphologies. They typically terminate in a bulb shape, linked to the dendritic shaft by a restriction. Spine remodeling is though to be involved in synaptic plasticity. |
| GO:0030426 | | growth cone | | The migrating motile tip of a growing nerve cell axon or dendrite. |
| GO:0030529 | | intracellular ribonucleoprotein complex | | An intracellular macromolecular complex containing both protein and RNA molecules. |
| GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| GO:0045121 | | membrane raft | | Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions. |
| GO:0043227 | | membrane-bounded organelle | | Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane. |
| GO:0005739 | | mitochondrion | | A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. |
| GO:0043025 | | neuronal cell body | | The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites. |
| GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| GO:0048471 | | perinuclear region of cytoplasm | | Cytoplasm situated near, or occurring around, the nucleus. |
| GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| GO:0043234 | | protein complex | | A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical. |